Nano-x Imaging Ltd · NASDAQ:NNOX
Nano-x Imaging — Investor Presentation (September 2026)
54 slides from Nano-x Imaging's investor presentation, September 2026
Slide 1: Nanox Investor Deck September 2026
Nanox Investor Deck September 2026
Slide 2: Disclaimer
Disclaimer Disclaimers Forward - Looking Information Statement (vi) Nanox ’s ability to enter into and maintain commercially reasonable arrangements This presentation has been prepared by NANO -X IMAGING with third - party manufacturers and suppliers to manufacture the Nanox.ARC; (vii) the This pres
Slide 3: This is Nanox
We are a NASDAQ - listed company (NASDAQ: NNOX), with offices in the US and Israel This is Our team is on a mission to deliver innovative, end - to- end imaging solutions, Nanox while building a customer - focused support structure like no other. We aim to transform global healthcare by enabling ear
Slide 4: End to end solutions
End to end solutions • Nanox’s connected ecosystem redefines how medical imaging is delivered and accessed worldwide. • Our integrated platform combines hardware, software, and cloud-based intelligence to make advanced imaging more accessible and affordable. 4
Slide 5: Business Updates
N <ALL * H| ES, 2 ‘ Hl i Business Updates — | .
Slide 6: Recent Business Updates
New U.S. Distribution Partner 1 Expanded Nanox ’s presence in the U.S. through additional distribution partner agreement. Capex Expansion 2 Advanced capital equipment sales through additional Nanox.ARC capex agreements, adding a deployed Nanox.ARC system to an internationally recognized orthopedic c
Slide 7: Technology & Platform
ul ‘hs ih | | fF achnc pays | hia
Slide 8: Behind the breakthrough
Proprietary Cold cathode Behind the breakthrough paired with Nanox multi source Tubes Nanox.SOURCE , our proprietary silicon - based, low - voltage, nano - scale cold cathode generates the electron stream needed for X - ray through field - emission technology. Replacing the traditional metal filamen
Slide 9: The Nanox difference
Understanding the technology The Nanox difference Standard Nanox.ARC X Nanox.SOURCE Technology X-Ray Tube Multi source Tubes Single tube producing limited Silicon Chip Five low - powered X - Ray Tubes linear projections (1.8kW) system 40 million nano - cones emitting Higher heat generation (up to el
Slide 10: The Nanox.ARC 3D Digital Multi Source
The Nanox.ARC 3 D Digital Multi Source 3 D tomosynthesis imaging system designed to integrate our proprietary and novel digital X - ray source and tube . Smaller, Lighter and Simpler X - ray System A less complex and smaller imaging system that aims to democratize advanced medical imaging Flexible B
Slide 11: The Nanox.ARC 3D Digital Multi Source
The Nanox.ARC 3 D Digital Multi Source 3 D tomosynthesis imaging system designed to integrate our proprietary and novel digital X- ray source and tube . Platform Capabilities • Low - Powered System • Quick Installation • Overhead Camera • Tablet - Operated • Local or Cloud - Based platform • Cable -
Slide 12: Nanox.ARC
Nanox.ARC Digital imaging system with multi - source 3 D tomosynthesis technology 12
Slide 13: Nanox.ARC Key Value
Nanox.ARC Key Value Affordable, advanced Propriety Cold Cathode Tomosynthesis Comprehensive customer digital 3 D imaging X- ray technology enables provides clinical support through training solution with a strong cost - saving, optimized benefits as anatomy program, remote. business viability. energ
Slide 14: U.S. Go-to-Market
‘Vat | U.S. Go-to- Market - '
Slide 15: Customer Targeting
Customer Targeting 1 Type of medical facility 2 General use Imaging capabilities 3 Geographic location, and sales coverage • Imaging Center • Urgent Care • 7- 10 scans per day • Experienced sales team provides • Orthopedic Clinic • Pulmonology • Including MSK, pulmonary, national coverage • Supporte
Slide 16: US Go To Market Direct Sales
US Go To Market Direct Sales Channel Partner Coverage Direct Sales Coverage Channel Partner Coverage CP 1 covers all states CP 1 all states CP 2 CP 3 CP 4 CP 5 CP 6 CP 7 CP 8 16
Slide 17: Nanox.ARC U.S. Professional Network
U.S. commercial team Corporate resources Nanox.ARC U.S. Product Marketing Professional Health IT Finance & Network R&D Operations USARAD Network Billing Corporate resources support every U.S. Sales & SDR Team US Channel Partners commercial function in market. Clinical & KOLs Medical Affairs Maintena
Slide 18: U.S. Business Model
U.S. Business Model MSAAS CAPEX and Hybrid, with MSaaS to CAPEX financing Conversion Per scan $ 30 Per System Convert to purchase Scans 7- 15 per day 18
Slide 19: Nanox U.S. Commercial Strategy
MSaaS Nanox ’s MSaaS Model Traditional Model (on a per scan basis) • Innovative MSaaS business model U.S. Scanning Reading Total • Nanox covers CapEx investment and CPT Code 76100 $58 –79 $30 $88 –109 deployment costs for systems Nanox Price $30 $20 $50 $170 –$200K Upfront • Covered procedure with e
Slide 20: Regulatory Pathway
Regulatory Pathway
Slide 21: Nanox Regulatory Clearances
Nanox Regulatory Clearances U.S. FDA 510(k) | General Use Nanox.ARC EU CE | Whole Body Current Clearance/ approval Israel AMAR | Whole Body Ghana GFDA | Whole Body Nanox.ARC X U.S. FDA 510(k) | General Use Current Clearance/ Israel AMAR | General Use approval TAP2D U.S. FDA 510(k) | SaMD Accessory f
Slide 22: United States, Europe, Rest of the World
UNITED STATES EUROPE REST OF THE WORLD 22
Slide 23: Nanox.ARC X
Nanox.ARC X 23
Slide 24: The future of imaging belongs to everyone
The future of imaging belongs to everyone Designed for access today. Ready for the intelligence of tomorrow. Discover Nanox.ARC X 24
Slide 25: Nanox.ARC
Nanox.ARC Built around our revolutionary technology, Nanox.ARC X bridges the gap between X - ray & CT. Standard X - ray can miss important detail. CT brings clarity, which may come with high cost, dose, and complexity. Nanox.ARC X delivers advanced 3 D insight with X - ray simplicity. 25
Slide 26: What if seeing more required less?
What if seeing more required less? 26
Slide 27: Nanox.ARC X Benefits
Nanox.ARC X | Benefits What if seeing more required less? Less Space Less Radiation Less power Requires only a 15x 10 80% less radiation than CT Uses a standard 110 foot room for equivalent body parts power outlet More Images More clarity More options Up to 200 coronal See through overlapping Billab
Slide 28: Clinical Value & Evidence
, " rT TM WW il) : ry | eaee eeeevensee pescesecse & seesecacans
Slide 29: Scenarios where Nanox.ARC X can help
Nanox.ARC X | Clinical Value Scenarios where * X- rays are inconclusive but CT may not be necessary Nanox.arc x can help * Metal artifacts obstructing anatomy on CT * Patient radiation exposure needs to be minimized * Subtle or complex findings require greater clarity * Follow - up or post - cast Na
Slide 30: Clinical value of digital tomosynthesis in orthopedics
DTS for MSK Clinical value of digital tomosynthesis in orthopedics Fractures with Occult Hip Scaphoid Osteoporotic Hip Casting Fractures Fractures Finds hidden breaks Reliable imaging & Facilitates Early detection & reduces false Clearly reveals subtle or evaluation without in elderly patients, ofte
Slide 31: Clinical Value of Digital Tomosynthesis in Articular Imaging
Clinical Value of Digital Tomosynthesis in Articular Imaging Articular & Structural Pathologies - Enhancing Evaluation Sacroiliitis Sacroiliitis Sacroiliitis C 7 –T 1 & Detection Detection Detection Odontoid & Grading & Grading & Grading Lesions Better visualization Enables more precise Improved vis
Slide 32: Nanox.ARC case studies
Nanox.ARC case studies Showcasing advanced clinical value 32
Slide 33: Modality comparison
Nanox.ARC X | Clinical Value Modality comparison X - Ray Nanox.ARC CT 2D DTS 3D Limited clarity on 3 D reconstruction. 3 D images. Image Quality overlapping anatomy Clearer view of overlapping structures Anatomic structures separated High: Low: Low: Radiation Dose CT: over 2 mSv 0.04 – 0.1 mSv 0.1 –
Slide 34: Modality comparison
Nanox.ARC X | Clinical Value Modality comparison X - Ray Nanox.ARC CT 2D DTS 3D 3 D images. Limited clarity on 3 D reconstruction. Image Quality overlapping anatomy Clearer view of overlapping structures Anatomic structures separated Low: Low: High:CT : over 2 mSv Radiation Dose 0.04 – 0.1 mSv 0.1 –
Slide 35: Obscured Lung Nodule
Clinical walkthrough Obscured Lung Nodule Peer - to Peer Video 35
Slide 36: Obscured Lung Nodule
Clinical walkthrough Obscured Lung Nodule X - ray CT Scan Nanox. ARC 36
Slide 37: Metal artifacts and occult hip fracture
Clinical walkthrough Metal artifacts and occult hip fracture Peer - to Peer Video 37
Slide 38: Metal artifacts and occult hip fracture
Clinical walkthrough Metal artifacts and occult hip fracture X - ray CT Scan Nanox. ARC 38
Slide 39: Testimonials
4 NANOXAI | , | iP ) J \\ | \ hi, 7.) ee | Ae i Ea W ye "te
Slide 40: 40
40
Slide 41: Testimonials
Testimonials “ The Nanox. ARC represents a unique advancement in medical imaging - tomosynthesis for whole body applications. I truly believe Nanox. ARC offers a unique opportunity and highly recommend that healthcare professionals and institutions explore this advanced technology ”. Lawrence Tanenb
Slide 42: Testimonials
Testimonials “ Digital tomosynthesis provides added value in certain clinical situations, MSK imaging, thoracic imaging, even abdominal imaging – all have particular use cases that may be best served by digital tomosynthesis compared to CT or X - ray. The Nanox system is unique in that it doesn ’t h
Slide 43: Ease of Adoption
Workflow Adopt ARC X Ease of Flexible Msaas Model or special financing through Adoption CaPex Model 1 2 3 Install Connect Operate Easy operation Up and running Intelligent deployment requires only 1 day in just one day on cloud - based system training for x - ray tech 43
Slide 44: Nanox.ARC X
Nanox.ARC X Centers who may benefit from our technology Specialists who may benefit from Nanox.ARC X Imaging centers Chiropractors Radiologists Orthopedic surgeons Orthopedic clinics Hospitals Sports medicine physicians Urgent care Pulmonologists ENT (otolaryngologists) 44
Slide 45: Nanox.AI
LLLP Lg lifts faeeness aen00. “CAMMY VX
Slide 46: Nanox.AI Solutions
Empower Medical Imaging To Improve Patient Care Nanox.AI Solutions 46
Slide 47: Broad Suite of Population Health Solutions
Broad Suite of Population Health Solutions Bone Solution Cardiac Solution Liver Solution Vertebral Height Loss Coronary Artery Liver Attenuation & Bone Mineral Density Calcium Measurement Measurement Metabolic Syndrome Associated Fatty Osteoporosis, Cardiovascular Liver Disease Osteopenia
Slide 48: Empowering Data to Improve Preventive Healthcare
Empowering Data With state - of- the - art medical AI technology, Nanox.AI leverages to Improve routine CT images to empower radiologists to help identify patients Preventive Healthcare with chronic diseases 48
Slide 49: AI Cardiac Proven Results
AI Cardiac Proven Results 4000 3,721 “ 3500 3000 “By using Nanox. AI ’s cardiac solution, Corewell Health significantly increased their ability to detect coronary calcification, identifying nearly 4,000 new patients in 2023 compared to just 268 patients 2500 having CAC reported in the previous two y
Slide 50: Proven Results
Proven Results Nanox.AI Software yields six - fold increase in spine fracture identification Nanox.AI Bone Solution identified over 3,450 new patients with vertebral compression fractures Patient identification – University Hospital Southampton NHS Foundation AI Software yields six - fold increase i
Slide 51: Nanox.AI customer testimonials
“These data demonstrate how AI - based calcium scoring could guide more effective prevention strategies and cardiovascular risk assessment for IMID patients and other often overlooked populations." Brittany Weber,MD Phd . Director, Cardio - Rheumatology Clinic, Division of Preventive Cardiology, Div
Slide 52: Financial Highlights
Financial Highlights 52
Slide 53: Q2/26 Financial Highlights
Q2 /26 Financial Highlights $ 31.4 M 72.5 M $ 31.6 M $ 4.2 M 77.6M (Q 2 /26 ) Fully Diluted Shares Cash and CE as of 6 /30 /26 Shareholders Equity PP&E Revenue Outstanding 53
Slide 54: Thank You
Thank You 54
Nano-X Imaging — Investor Presentation (September 2026) on 6ix